Endometrial Ablation Devices Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI3783
Endometrial Ablation Devices Market size is projected to experience significant growth from 2019 to 2025.
Increasing incidence of gynecological disorders and endometrial cancer in women will stimulate global endometrial ablation devices business growth in the coming years. According to the American Cancer Society (ACS), in 2019, in the U.S. about 4,250 women died from cervical cancer and nearly 13,170 new cases will be diagnosed. Thus, rise in number of these cases will fuel endometrial ablation devices market growth over the forecast timeframe.
Increasing awareness about the endometrial ablation devices coupled with technological advancements in the ablation procedures will upsurge endometrial ablation devices market size over the forecast timeframe. In addition, the endometrial ablation devices have various advantages such as efficiency, speed of treatment, a lower rate of site effective and post-surgery hospitalization. Aforementioned factors will offer lucrative market growth.
However, the high cost associated with ablation procedures coupled with lack of reimbursement policies may restrain the market demand. Furthermore, stringent regulatory procedures may limit product approvals, thereby hampering the market growth.
Radiofrequency endometrial ablation devices market will hold a significant revenue size over the forecast years. It is widely used in healthcare institutions due to its extensive features such as high safety, fast recovery, convenience, speed of treatment, ease of use, effectiveness, and efficiency. Furthermore, increasing healthcare expenditure, high preference from several medical practitioners, rising awareness related to this technique and emerging market economies will offer growth opportunities in the forthcoming period.
Hospitals segment will show momentous growth owing to availability of improved and advanced technology-based endometrial ablation techniques in these facilities. Additionally, increasing endometrial ablation procedures in hospital settings coupled with numerous reimbursement policies will drive business growth. Furthermore, a growing number of hospitalizations towards gynecological disorders will drive the segmental growth during the projection timeframe.
U.S. endometrial ablation devices market is estimated to foresee a lucrative growth over the forecast period due to the growing sedentary lifestyle and overwork in women is susceptible to abnormal uterine bleeding such as menorrhagia and other menstrual disorders. Additionally, increasing awareness about endometrial ablation technologies and high adoption of advanced ablation procedures will drive market growth. Moreover, the presence of well-developed healthcare infrastructure coupled with supportive government initiatives will accelerate endometrial ablation devices market growth.
Asia Pacific is estimated to witness lucrative growth over the forecast period due to increasing accessibility and availability of innovative endometrial ablation procedures in this region. Furthermore, increasing investment in the healthcare sector coupled with supportive government policies, rising public awareness related to abnormal uterine bleeding and increasing demand for minimally invasive procedures will drive the market growth in the forecast period.
Few of the key companies operating in endometrial ablation devices market share include Boston Scientific Corporation, Olympus Corporation, Minerva Surgical, Inc., Smith & Nephew and The Cooper Companies Inc. Firms are adopting new product launch, merger & acquisition strategies to increase their market footprint. For instance, in February 2018, Hologic, Inc., a global leading player in the market, received the U.S. FDA approval for NovaSure, an advanced global endometrial ablation system. The system is designed to reduce abdominal uterine bleeding by applying Radiofrequency energy (RFE). This strategy will strengthen the company’s market position.
Endometrial Ablation Devices Market by Technology, 2014-2025 (USD Million)
- Radiofrequency Ablation
- Hydrothermal Ablation
- Thermal Balloon
- Hysteroscopic Ablation
Endometrial Ablation Devices Industry by End-use, 2014-2025 (USD Million)
- Ambulatory Surgical Centers
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Hologic, Inc.
- Boston Scientific Corporation
- Olympus Corporation
- Minerva Surgical, Inc.
- Smith & Nephew
- The Cooper Companies Inc.
- Karl Storz GmbH & Co. KG
- Richard Wolf GmbH
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.